Encompass Health Corp·4

Feb 20, 3:38 PM ET

Tuer Patrick William 4

4 · Encompass Health Corp · Filed Feb 20, 2026

Research Summary

AI-generated summary of this filing

Updated

Encompass Health (EHC) COO Patrick Tuer Receives Restricted Stock

What Happened
Patrick William Tuer, Chief Operating Officer of Encompass Health Corp (EHC), was issued a total of 14,044 restricted shares in two awards: 10,254 shares on 2026-02-18 and 3,790 shares on 2026-02-19. Each grant was recorded at $0.00 per share (award/compensation), so no cash was paid for the shares. One issuance (10,254 shares) reflects satisfaction of performance criteria tied to a February 23, 2023 performance share unit award; the other (3,790 shares) is the annual restricted stock award under the company’s 2025 Omnibus Performance Incentive Plan.

Key Details

  • Transaction dates and prices: 2026-02-18 — 10,254 shares @ $0.00; 2026-02-19 — 3,790 shares @ $0.00.
  • Total shares received: 14,044 restricted shares; total cash paid reported: $0.00.
  • Shares owned after transaction: not specified in the provided filing summary.
  • Footnotes: F1 — issuance resulted from satisfaction of PSU performance criteria (award dated 2/23/2023). F2 — annual award under the 2025 Omnibus Performance Incentive Plan.
  • Filing timeliness: filing dated 2026-02-20 for transactions on 2/18 and 2/19; filing appears timely under Form 4 reporting rules.

Context
Restricted stock awards are a form of compensation and often carry vesting or other transfer restrictions; they are not open-market purchases and do not directly indicate buying or selling sentiment. The $0 acquisition price is standard for compensation grants; the F1 item shows part of this issuance was tied to prior performance-based awards that vested or converted upon meeting performance criteria.

Insider Transaction Report

Form 4
Period: 2026-02-18
Tuer Patrick William
EVP, Chief Operating Officer
Transactions
  • Award

    Encompass Health Common Stock

    [F1]
    2026-02-18+10,25426,296 total
  • Award

    Encompass Health Common Stock

    [F2]
    2026-02-19+3,79030,086 total
Footnotes (2)
  • [F1]This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023.
  • [F2]Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.
Signature
/s/ Patrick Darby, attorney-in-fact for Patrick W. Tuer|2026-02-20

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT